General model of inflammation

Bulletin of Mathematical Biology

Volumn 72, Issue 4, 2010, Pages 765-779

  Herald, Meagan C ^a  

^a VIRGINIA MILITARY INSTITUTE   (United States)

Author keywords

Chronic inflammation; Cytokine; Macrophage; Respiratory

Indexed keywords

ARTICLE; BIOLOGICAL MODEL; COMPUTER SIMULATION; HUMAN; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY;

COMPUTER SIMULATION; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MODELS, IMMUNOLOGICAL;

BACTERIA (MICROORGANISMS);

EID: 77952670011     PISSN: 00928240     EISSN: 15229602     Source Type: Journal    
DOI: 10.1007/s11538-009-9468-9     Document Type: Article

References (29)

1. Abbas, A. K., Lichtman, A. H., Pober, J. S., 2000. Cellular and Molecular Immunology, 4th edn. Saunders, Philadelphia.
2. Aldallal, N., McNaughton, E. E., Manzel, L. J., Richards, A. M., Zabner, J., Ferkol, T. W., Look, D. C., 2002. Inflammatory response in airway epithelial cells isolated from patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 166, 1248-1256.
3. Bonfield, T. L., Konstan, M. W., Burfeind, P., Panuska, J. R., Hilliard, J. B., Berger, M., 1995. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 13, 257-261.
4. Costerton, W., Veeh, R., Shirtliff, M., Pasmore, M., Post, C., Ehrlich, G., 2003. The application of biofilm science to the study and control of chronic bacterial infections. J. Clin. Invest. 112(10), 1466-1477.
5. Danese, S., Semeraro, S., Armuzzi, A., Papa, A., Gasbarrini, A., 2006. Biological therapies for inflammatory bowel disease: research drives clinics. Mini Rev. Medicinal Chem. 6(7), 771-784.
6. Day, J., Rubin, J., Vodovotz, Y., Chow, C. C., Reynolds, A., Clermont, G., 2006. A reduced mathematical model of the acute inflammatory response: II. Capturing scenarios of repeated endotoxin administration. J. Theor. Biol. 242, 237-256.
7. DeRose, V., 2002. Mechanisms and markers of airway inflammation in cystic fibrosis. Eur. Respir. J. 19, 333-340.
8. Ferkol, T. W., Look, D. C., 2001. Chincks in the armor or the airway. Am. J. Respir. Cell Molec. Biol. 25, 11-13.
9. Goldsby, R. A., Kindt, T. J., Kuby, J., Osborne, B. A., 2002. Immunology, 5th edn. Freeman, New York.
10. Janeway, C. A., Travers, P., Walport, M., Shlomchik, M. J., 2005. Immunobiology the Immune System in Health and Disease, 6th edn. Garland Science, New York.
11. Jesaitis, A. J., Franklin, M. J., Berglund, D., Sasaki, M., Lord, C. I., Bleazard, J. B., Duffy, J. E., Beyenal, H., Lewandowski, Z., 2003. Compromised host defense on Pseudomonas aeruginosa biofilms: Characterization of neutrophil and biofilm interactions. J. Immunol. 171, 4329-4339.
12. Kumar, R., Clermont, G., Vodovotz, Y., Chow, C. C., 2004. The dynamics of acute inflammation. J. Theor. Biol. 230, 145-155.
13. Löfdahl, J. M., Wahlström, J., Sköld, C. M., 2006. Different inflammatory cell pattern and macrophage phenotype in chronic obstructive pulmonary disease patients, smokers and non-smokers. Clin. Exp. Immunol. 145, 428-437.
14. Machen, T. E., 2006. Innate immune response in CF airway epithelia: hyperinflammatory? Am. J. Physiol., Cell Physiol. 291, C218-C230.
15. McCormack, F. X., Whitsett, J. A., 2002. The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J. Clin. Invest. 109(6), 707-712.
16. Mosser, D. M., 2003. The many faces of macrophage activation. J. Leukoc. Biol. 73, 209-212.
17. Muhlbach, M. S., Stewart, P. W., Leigh, M. W., Noah, T. L., 1999. Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. Am. J. Respir. Crit. Care Med. 160, 186-191.
18. Murray, J. D., 1993. Mathematical Biology, 2nd edn. Springer, Berlin.
19. O'Donnell, R., Breen, D., Wilson, S., Djukanovic, R., 2006. Inflammatory cells in the airways in COPD. Thorax 61, 448-454.
20. Reynolds, A., Rubin, J., Clermont, G., Day, J., Vodovotz, Y., Ermentrout, G. B., 2006. A reduced mathematical model of the acute inflammatory response: I. Derivation of model and analysis of anti-inflammation. J. Theor. Biol. 242, 220-236.
21. Rosell, A., Monsó, E., Soler, M., Torress, F., Angrill, J., Riise, G., Zalacaín, R., Morera, J., Torres, A., 2005. Microbiological determinants of exacerbation in chronic obstructive pulmonary disease. Arch. Intern. Med. 165, 891-897.
22. Thomson, A. (Ed.), 1998. The Cytokine Handbook, 3rd edn. Academic Press, San Diego.
23. Tirouvanziam, R., de Bentzmann, S., Hubeau, C., Hinnrasky, J., Jacquot, J., Péault, B., Puchelle, E., 2000. Inflammation and infection in naive human cystic fibrosis airway grafts. Am. J. Respir. Cell Mol. Biol. 23, 121-127.
24. Tirouvanziam, R., Khazaal, I., Péault, B., 2002. Primary inflammation in human cystic fibrosis small airways. Am. J. Physiol., Lung Cell. Mol. Physiol. 283, L445-L451.
25. Tran, C. L., Jones, A. D., Cullen, R. T., Donaldson, K., 1999. Mathematical modeling of the retention and clearance of low-toxicity particles in the lung. Inhalation Toxicol. 11(12), 1059-1076.
26. Vodovotz, Y., Clermont, G., Chow, C., An, G., 2004. Mathematical models of the acute inflammatory response. Curr. Opin. Crit. Care 10(5), 383-390.
27. West, J. B., 2003. Pulmonary Pathophysiology: The Essentials, 6th edn. Lippincott, Baltimore.
28. Wigginton, J. E., Kirschner, D., 2001. A model to predict cell-mediated immune reulatory mechanisma during humman infection with Mycobacterium tuberculosis. J. Immunol. 1951-1967.
29. Zaman, M. M., Gelrud, A., Junaidi, O., Regan, M. M., Warny, M., Shea, J. C., Kelly, C., O'Sullivan, B. P., Freedman, S. D., 2004. Interleukin 8 secretion from monocytes of subjects heterozygous for the δF508 cystic fibrosis transmembrane conductance regulator gene mutation is altered. Clin. Diagn. Lab. Immunol. 819-824.